Total Payments
$79,185
2022 Payments
$232.49
Companies
6
Transactions
105
Medicare Patients
18,449
Medicare Billing
$884,790
Payment Breakdown by Category
Other$67,750 (85.6%)
Travel$7,499 (9.5%)
Food & Beverage$3,546 (4.5%)
Consulting$300.00 (0.4%)
Education$90.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,750 | 24 | 85.6% |
| Travel and Lodging | $7,499 | 30 | 9.5% |
| Food and Beverage | $3,546 | 49 | 4.5% |
| Consulting Fee | $300.00 | 1 | 0.4% |
| Education | $90.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $75,505 | 79 | $0 (2022) |
| Terumo Medical Corporation | $1,215 | 10 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $1,012 | 6 | $0 (2017) |
| Siemens Medical Solutions USA, Inc. | $939.85 | 6 | $0 (2017) |
| Abbott Laboratories | $417.29 | 3 | $0 (2018) |
| GE Healthcare | $97.19 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $232.49 | 2 | Janssen Pharmaceuticals, Inc ($232.49) |
| 2020 | $322.40 | 2 | Janssen Pharmaceuticals, Inc ($322.40) |
| 2019 | $20,956 | 23 | Janssen Pharmaceuticals, Inc ($20,956) |
| 2018 | $32,072 | 41 | Janssen Pharmaceuticals, Inc ($30,343) |
| 2017 | $25,603 | 37 | Janssen Pharmaceuticals, Inc ($23,651) |
All Payment Transactions
105 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $120.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/01/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $111.53 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $22.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $84.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $101.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | Cash or cash equivalent | $51.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $653.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $174.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $46.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $80.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $22.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,337 | 7,005 | $1.1M | $210,286 |
| 2022 | 32 | 4,159 | 6,704 | $1.1M | $212,505 |
| 2021 | 35 | 4,943 | 7,792 | $1.2M | $245,200 |
| 2020 | 34 | 5,010 | 7,376 | $918,818 | $216,800 |
Total Patients
18,449
Total Services
28,877
Medicare Billing
$884,790
Procedure Codes
169
All Medicare Procedures & Services
169 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 381 | 398 | $283,622 | $31,778 | 11.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 487 | 513 | $98,232 | $29,428 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 249 | $81,280 | $24,041 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 215 | $50,442 | $14,764 | 29.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 203 | 205 | $47,150 | $13,635 | 28.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 63 | 63 | $156,089 | $13,025 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 107 | 156 | $28,540 | $11,836 | 41.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 75 | 75 | $31,272 | $9,985 | 31.9% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 131 | 133 | $51,857 | $7,906 | 15.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 78 | 79 | $23,305 | $7,100 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 50 | 50 | $14,000 | $5,437 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 106 | 113 | $9,831 | $5,401 | 54.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 45 | 51 | $24,378 | $4,781 | 19.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 48 | $10,392 | $3,208 | 30.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 369 | 421 | $9,683 | $2,872 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 26 | $9,502 | $2,681 | 28.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $9,669 | $2,635 | 27.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 198 | 201 | $28,538 | $2,441 | 8.6% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 29 | 58 | $15,022 | $2,045 | 13.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 197 | 200 | $68,623 | $1,989 | 2.9% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 62 | 62 | $6,331 | $1,896 | 29.9% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 265 | 269 | $5,380 | $1,599 | 29.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 68 | 70 | $4,866 | $1,471 | 30.2% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Office | 2023 | 34 | 34 | $3,482 | $1,090 | 31.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 164 | 165 | $3,795 | $1,063 | 28.0% |
About Dr. Michael Longo, MD
Dr. Michael Longo, MD is a Cardiovascular Disease healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508838467.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Longo, MD has received a total of $79,185 in payments from pharmaceutical and medical device companies, with $232.49 received in 2022. These payments were reported across 105 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($67,750).
As a Medicare-enrolled provider, Longo has provided services to 18,449 Medicare beneficiaries, totaling 28,877 services with total Medicare billing of $884,790. Data is available for 4 years (2020–2023), covering 169 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Seattle, WA
- Active Since 02/06/2006
- Last Updated 08/31/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1508838467
Products in Payments
- XARELTO (Drug) $75,505
- Optitorque (Device) $1,099
- WATCHMAN (Device) $998.87
- SC2000 (Device) $939.85
- Mitra Clip system (Device) $417.29
- TR Band (Device) $17.88
- WATCHMAN DEVICE (Device) $12.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Seattle
William Lombardi, M.d, M.D
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Wayne Levy
Cardiovascular Disease — Payments: $412,349
Cardiovascular Disease $412,349
Kathleen Kearney, M.d, M.D
Cardiovascular Disease — Payments: $394,462
Cardiovascular Disease $394,462
Gary Oppenheim, M.d, M.D
Cardiovascular Disease — Payments: $264,512
Cardiovascular Disease $264,512
Kelley Branch
Cardiovascular Disease — Payments: $207,371
Cardiovascular Disease $207,371
Dr. Erik Wissner, M.d, M.D
Cardiovascular Disease — Payments: $186,373
Cardiovascular Disease $186,373